Sfoglia per AUTORE
MERLANO M
Collezione AO Cuneo

  

Items : 38

Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma. in Oral oncology / Oral Oncol. 2023 Oct;145:106540. doi: 10.1016/j.oraloncology.2023.106540. Epub 2023 Aug 9.
2023
AO Cuneo

Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P;

In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment. in Oral oncology / Oral Oncol. 2022 Jan;124:105640. doi: 10.1016/j.oraloncology.2021.105640. Epub 2021 Nov 26.
2022
AO Cuneo

Garrone O; Denaro N; Merlano M;

Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib. in World journal of gastrointestinal oncology / World J Gastrointest Oncol. 2020 Mar 15;12(3):301-310. doi: 10.4251/wjgo.v12.i3.301.
2020
AO Cuneo

Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano MC; Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano MC;

Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo

Russi E; Merlano MC; Merlotti AM; Denaro N; Denaro N; Merlotti AM; Merlano MC; Russi E;

Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo

Russi E; Merlano MC; Merlotti AM; Denaro N; Denaro N; Merlotti AM; Merlano MC; Russi E;

2020
AO Cuneo

Polimeni A; Vici P; Salati M; Ronzino G; Pizzuti L; Cortellini A; Cassano A; Di Dio C; Cirillo A; Mammone G; Roberto M; Cerbelli B; Sciattella P; Pomati G; Mezi S; Botticelli A; Merlano MC; Nuti M; Marchetti P;

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). in Journal for immunotherapy of cancer / J Immunother Cancer. 2019 Nov 29;7(1):332. doi: 10.1186/s40425-019-0798-3.
2019
AO Cuneo

Ascierto PA; Bifulco C; Buonaguro L; Emens LA; Ferris RL; Fox BA; Delgoffe GM; Galon J; Gridelli C; Merlano M; Nathan P; Odunsi K; Okada H; Paulos CM; Pignata S; Schalper KA; Spranger S; Tortora G; Zarour H; Butterfield LH; Puzanov I; Ascierto PA; Bifulco C; Buonaguro L; Emens LA; Ferris RL; Fox BA; Delgoffe GM; Galon J; et alii...

2019
AO Cuneo

Merlano MC; Denaro N;

How I treat squamous ENT cancer. in ESMO open / ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019.
2019
AO Cuneo

Galizia D; Denaro N; Merlano MC; Garrone O;

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events. in PloS one / PLoS One. 2019 Mar 20;14(3):e0213934. doi: 10.1371/journal.pone.0213934. eCollection 2019.
2019
AO Cuneo
AOU Città della Salute di Torino

Berruti A; Magrini SM; Resteghini C; Nicolai P; Tonoli S; Maroldi R; Pronzato P; Alfieri S; Rossetto C; Ibrahim T; Carlini P; Merlano M; Airoldi M; Conte P; Bergamini C; Vecchio S; Bonetta A; Triggiani L; Locati LD; Bianchi S; Grisanti S;

2018
AO Cuneo

Merlano M; Audhuy F; Schulten J; García-Foncillas J; Trotta AM; Lenz HJ; Ferris RL; Milano G;

Immunotherapy in Head and Neck Squamous Cell Cancer. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2018 Dec;11(4):217-223. doi: 10.21053/ceo.2018.00150. Epub 2018 Jul 6.
2018
AO Cuneo

Merlano MC; Denaro N;

Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials. in Head & neck / Head Neck. 2018 Dec;40(12):2648-2656. doi: 10.1002/hed.25389. Epub 2018 Nov 17.
2018
AO Cuneo

Bossi P; Miceli R; Benasso M; Corvò R; Bacigalupo A; Sanguineti G; Fallai C; Merlano MC; Infante G; Dani C; Di Giannantonio V; Licitra L;

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it? in ESMO open / ESMO Open. 2018 Jun 20;3(4):e000404. doi: 10.1136/esmoopen-2018-000404. eCollection 2018.
2018
AO Cuneo

Garrone O; Merlano MC;

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344.
2017
AO Cuneo

Cohen EEW; Licitra LF; Burtness B; Fayette J; Gauler T; Clement PM; Grau JJ; Del Campo JM; Mailliez A; Haddad RI; Vermorken JB; Tahara M; Guigay J; Geoffrois L; Merlano MC; Dupuis N; Krämer N; Cong XJ; Gibson N; Solca F; Ehrnrooth E; Machiels JH;

MicroRNAs role as potential biomarkers and key regulators in melanoma. in Genes, chromosomes & cancer / Genes Chromosomes Cancer. 2017 Jan;56(1):3-10. doi: 10.1002/gcc.22402. Epub 2016 Oct 25.
2017
AO Cuneo

Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C;

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies. in Oncotarget / Oncotarget. 2017 Feb 7;8(6):9174-9188. doi: 10.18632/oncotarget.13942.
2017
AO Cuneo

Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G;

Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population. in Archives of medical research / Arch Med Res. 2017 Feb;48(2):156-161. doi: 10.1016/j.arcmed.2017.03.008.
2017
AO Cuneo
ASL Cuneo 1

Merlano M; Vado A; Mussapi F; Leto L; Astesana V; Testa M; Vivenza D; Monteverde M; Feola M; Lo Nigro C;

Heterogeneity of colon cancer: from bench to bedside. in ESMO open / ESMO Open. 2017 Aug 22;2(3):e000218. doi: 10.1136/esmoopen-2017-000218. eCollection 2017.
2017
AO Cuneo

Merlano MC; Granetto C; Fea E; Ricci V; Garrone O;

Head and neck cancer: improving outcomes with a multidisciplinary approach. in Cancer management and research / Cancer Manag Res. 2017 Aug 18;9:363-371. doi: 10.2147/CMAR.S115761. eCollection 2017.
2017
AO Cuneo

Lo Nigro C; Denaro N; Merlotti A; Merlano M;

Reoxygenation Reverses Hypoxia-related Radioresistance in Head and Neck Cancer Cell Lines. in Anticancer research / Anticancer Res. 2016 May;36(5):2211-5.
2016
AO Cuneo

Tonissi F; Lattanzio L; Astesana V; Cavicchioli F; Ghiglia A; Monteverde M; Vivenza D; Gianello L; Russi E; Merlano M; Lo Nigro C;

Schedule-dependent interaction between temsirolimus and cetuximab in head and neck cancer: a preclinical study. in Anti-cancer drugs / Anticancer Drugs. 2016 Jul;27(6):533-9. doi: 10.1097/CAD.0000000000000360.
2016
AO Cuneo

Lattanzio L; Milano G; Monteverde M; Tonissi F; Vivenza D; Merlano M; Lo Nigro C;

Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis. in The oncologist / Oncologist. 2016 Jan;21(1):59-71. doi: 10.1634/theoncologist.2015-0246. Epub 2015 Dec 28.
2016
AO Cuneo

Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J;

Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients. in World journal of gastrointestinal oncology / World J Gastrointest Oncol. 2016 Feb 15;8(2):222-30. doi: 10.4251/wjgo.v8.i2.222.
2016
AO Cuneo

Lo Nigro C; Ricci V; Vivenza D; Monteverde M; Strola G; Lucio F; Tonissi F; Miraglio E; Granetto C; Fortunato M; Merlano MC;

Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2016 Dec;9(4):287-297. doi: 10.21053/ceo.2015.00976. Epub 2016 Jun 25.
2016
AO Cuneo

Denaro N; Merlano MC; Russi EG;

Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy. in World journal of gastroenterology / World J Gastroenterol. 2016 Aug 14;22(30):6944-54. doi: 10.3748/wjg.v22.i30.6944.
2016
AO Cuneo

Lo Nigro C; Ricci V; Vivenza D; Granetto C; Fabozzi T; Miraglio E; Merlano MC;

The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):179-90. doi: 10.1016/j.critrevonc.2015.02.014. Epub 2015 Mar
2015
AO Cuneo

Monteverde M; Milano G; Strola G; Maffi M; Lattanzio L; Vivenza D; Tonissi F; Merlano M; Lo Nigro C;

Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):191-213. doi: 10.1016/j.critrevonc.2015.03.003. Epub 2015 Mar
2015
AO Cuneo
AOU Città della Salute di Torino

Vermorken JB; Raber-Durlacher J; Bernier J; Cascio A; Pergolizzi S; Buglione M; Caspiani O; Denaro N; Moretto F; Licitra L; Merlano MC; Ghi MG; Merlotti A; Musso S; De Sanctis V; Bacigalupo A; Crippa F; Bossi P; Numico G; Russi EG; Mirabile A; Murphy B; Ranieri MV; Dellinger RP;

Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective. in Anticancer research / Anticancer Res. 2014 Dec;34(12):6887-96.
2014
AO Cuneo

Denaro N; Merlano MC; Russi EG; Lo Nigro C;

State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. in Oncology / Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10.
2014
AO Cuneo

Denaro N; Russi EG; Adamo V; Merlano MC;

Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2013 Sep;6(3):117-26. doi: 10.3342/ceo.2013.6.3.117. Epub 2013 Sep 4.
2013
AO Cuneo

Denaro N; Merlano MC; Russi EG;

The role of antiangiogenic agents in the treatment of head and neck cancer. in Oncology / Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9.
2012
AO Cuneo

Denaro N; Russi EG; Colantonio I; Adamo V; Merlano MC;

The Role of p53 and MDM2 in Head and Neck Cancer. in ISRN otolaryngology / ISRN Otolaryngol. 2011 Dec 7;2011:931813. doi: 10.5402/2011/931813. Print 2011.
2011
AO Cuneo

Denaro N; Lo Nigro C; Natoli G; Russi EG; Adamo V; Merlano MC;

Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer. in International journal of oncology / Int J Oncol. 2010 Nov;37(5):1219-28. doi: 10.3892/ijo_00000773.
2010
AO Cuneo

Lo Nigro C; Monteverde M; Riba M; Lattanzio L; Tonissi F; Garrone O; Heouaine A; Gallo F; Ceppi M; Borghi F; Comino A; Merlano M;

Impact of erythropoietin on the effects of irradiation under hypoxia. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5.
2009
AO Cuneo

Lo Nigro C; Maffi M; Fischel JL; Monteverde M; Catarsi P; Tonissi F; Lattanzio L; Riba M; Etienne-Grimaldi MC; Formento P; Milano G; Merlano M;

The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data. in BJU international / BJU Int. 2008 Aug 5;102(5):622-7. doi: 10.1111/j.1464-410X.2008.07706.x. Epub 2008 May 20.
2008
AO Cuneo

Lo Nigro C; Maffi M; Fischel JL; Formento P; Milano G; Merlano M;

Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study. in American journal of clinical oncology / Am J Clin Oncol. 2001 Dec;24(6):618-22. doi: 10.1097/00000421-200112000-00019.
2001
AO Cuneo

Benasso M; Merlano M; Sanguineti G; Corvò R; Numico G; Ricci I; Pallestrini E; Santelli A; Vitale V; Marchetti G; Rosso R;

[The treatment of laryngeal cancer. Chemotherapeutic treatment]. in Recenti progressi in medicina / Recenti Prog Med. 1998 Dec;89(12):647-50.
1998
AO Cuneo

Merlano M; Garrone O;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte